© 2003 by Oxford University Press
© 2003 Oxford University Press
ARTICLE |
Population Attributable Risks of Esophageal and Gastric Cancers
Affiliations of authors: L. S. Engel, W.–H. Chow, M. H. Gail, J. F. Fraumeni, Jr., Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; T. L. Vaughn, J. L. Stanford, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, and Department of Epidemiology, University of Washington, Seattle, WA; M. D. Gammon, School of Public Health, University of North Carolina, Chapel Hill; H. A. Risch, S. T. Mayne, R. Dubrow, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT; J. B. Schoenberg (retired), Cancer Epidemiology Services, New Jersey Department of Health and Senior Services, Trenton, NJ; H. Rotterdam, Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, NY; A. B. West, Department of Pathology, New York University, New York, NY; M. Blaser, Department of Medicine, New York University School of Medicine, New York, NY; W. J. Blot, International Epidemiology Institute, Rockville, MD.
Correspondence to: Lawrence Engel, PhD, Memorial Sloan–Kettering Cancer Center, Epidemiology Service, 307 E. 63rd St., 3rd Floor, New York, NY 10021 (e-mail: engell{at}mskcc.org).
Background: Several risk factors have been identified for esophageal adenocarcinoma, gastric cardia adenocarcinoma, esophageal squamous cell carcinoma, and noncardia gastric adenocarcinoma, but no study has comprehensively examined their contributions to the cancer burden in the general population. Herein, we estimate the population attributable risks (PARs) for various risk factors observed in a multicenter population–based case–control study. Methods: We calculated PARs by using 293 patients with esophageal adenocarcinoma, 261 with gastric cardia adenocarcinoma, 221 with esophageal squamous cell carcinoma, 368 with noncardia gastric adenocarcinoma, and 695 control subjects. We included smoking for all four tumor types and Helicobacter pylori infection for noncardia gastric adenocarcinoma as established causal risk factors as well as several other factors for which causality is under evaluation. Results: Ever smoking, body mass index above the lowest quartile, history of gastroesophageal reflux, and low fruit and vegetable consumption accounted for 39.7% (95% confidence interval [CI] = 25.6% to 55.8%), 41.1% (95% CI = 23.8% to 60.9%), 29.7% (95% CI = 19.5% to 42.3%), and 15.3% (95% CI = 5.8% to 34.6%) of esophageal adenocarcinomas, respectively, with a combined PAR of 78.7% (95% CI = 66.5% to 87.3%). Ever smoking and body mass index above the lowest quartile were responsible for 45.2% (95% CI = 31.3% to 59.9%) and 19.2% (95% CI = 4.9% to 52.0%) of gastric cardia adenocarcinomas, respectively, with a combined PAR of 56.2% (95% CI = 38.1% to 72.8%). Ever smoking, alcohol consumption, and low fruit and vegetable consumption accounted for 56.9% (95% CI = 36.6% to 75.1%), 72.4% (95% CI = 53.3% to 85.8%), and 28.7% (95% CI = 11.1% to 56.5%) of esophageal squamous cell carcinomas, respectively, with a combined PAR of 89.4% (95% CI = 79.1% to 95.0%). Ever smoking, history of gastric ulcers, nitrite intake above the lowest quartile, and H. pylori infection were responsible for 18.3% (95% CI = 6.5% to 41.8%), 9.7% (95% CI = 5.4% to 16.8%), 40.7% (95% CI = 23.4% to 60.7%), and 10.4% (95% CI = 0.3% to 79.6%) of noncardia gastric adenocarcinomas, respectively, with a combined PAR of 59.0% (95% CI = 16.2% to 91.4%). Conclusion: In this population, a few known risk factors account for a majority of esophageal and gastric cancers. These results suggest that the incidence of these cancers may be decreased by reducing the prevalence of smoking, gastroesophageal reflux, and being overweight and by increasing the consumption of fruits and vegetables.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K K Teo, L Liu, C K Chow, X Wang, S Islam, L Jiang, J E Sanderson, S Rangarajan, S Yusuf, and for the INTERHEART Investigators in China Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study Heart, November 15, 2009; 95(22): 1857 - 1864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Y. Cheung, R. Zhai, M. H. Kulke, R. S. Heist, K. Asomaning, C. Ma, Z. Wang, L. Su, M. Lanuti, K. K. Tanabe, et al. Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk Carcinogenesis, August 1, 2009; 30(8): 1363 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Bradbury, R. Zhai, J. Hopkins, M. H. Kulke, R. S. Heist, S. Singh, W. Zhou, C. Ma, W. Xu, K. Asomaning, et al. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis Carcinogenesis, May 1, 2009; 30(5): 793 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. M Thompson, S. A. Beresford, E. A Kirk, and T. L Vaughan Vegetable and fruit intakes and risk of Barrett's esophagus in men and women Am. J. Clinical Nutrition, March 1, 2009; 89(3): 890 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Abnet, F. Kamangar, F. Islami, D. Nasrollahzadeh, P. Brennan, K. Aghcheli, S. Merat, A. Pourshams, H. A. Marjani, A. Ebadati, et al. Tooth Loss and Lack of Regular Oral Hygiene Are Associated with Higher Risk of Esophageal Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3062 - 3068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Santibanez, J Vioque, J Alguacil, X Barber, M Garcia de la Hera, T Kauppinen, and for the PANESOES Study Group Occupational exposures and risk of oesophageal cancer by histological type: a case-control study in eastern Spain Occup. Environ. Med., November 1, 2008; 65(11): 774 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Stoner, A. A. Dombkowski, R. K. Reen, D. Cukovic, S. Salagrama, L.-S. Wang, and J. F. Lechner Carcinogen-Altered Genes in Rat Esophagus Positively Modulated to Normal Levels of Expression by Both Black Raspberries and Phenylethyl Isothiocyanate Cancer Res., August 1, 2008; 68(15): 6460 - 6467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sadeghi, C. J. Bain, N. Pandeya, P. M. Webb, A. C. Green, D. C. Whiteman, and for the Australian Cancer Study Aspirin, Nonsteroidal Anti-inflammatory Drugs, and the Risks of Cancers of the Esophagus Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1169 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Demma, R. C. Holman, J. Sobel, K. L. Yorita, T. W. Hennessy, E. L. Paisano, and J. E. Cheek Epidemiology of Hospitalizations Associated with Ulcers, Gastric Cancers, and Helicobacter pylori Infection among American Indian and Alaska Native Persons Am J Trop Med Hyg, May 1, 2008; 78(5): 811 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Risques, T. L. Vaughan, X. Li, R. D. Odze, P. L. Blount, K. Ayub, J. L. Gallaher, B. J. Reid, and P. S. Rabinovitch Leukocyte Telomere Length Predicts Cancer Risk in Barrett's Esophagus Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2649 - 2655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Healy, A. M. Ryan, B. Gopinath, S. Rowley, P. J. Byrne, and J. V. Reynolds Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1284 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dehghan, M. van Hoek, E. J.G. Sijbrands, T. Stijnen, A. Hofman, and J. C.M. Witteman Risk of Type 2 Diabetes Attributable to C-Reactive Protein and Other Risk Factors Diabetes Care, October 1, 2007; 30(10): 2695 - 2699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yang, Y. Guo, X. Zhang, X. Miao, W. Tan, T. Sun, D. Zhao, D. Yu, J. Liu, and D. Lin Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer Carcinogenesis, September 1, 2007; 28(9): 1996 - 2001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, Q. Ke, W. Chen, J. Wang, Y. Tan, Y. Zhou, Z. Hua, W. Ding, J. Niu, J. Shen, et al. Polymorphisms of MTHFD, Plasma Homocysteine Levels, and Risk of Gastric Cancer in a High-Risk Chinese Population Clin. Cancer Res., April 15, 2007; 13(8): 2526 - 2532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Nagel, J. Linseisen, H. C Boshuizen, G. Pera, G. Del Giudice, G. P Westert, H B. Bueno-de-Mesquita, N. E Allen, T. J Key, M. E Numans, et al. Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) Int. J. Epidemiol., March 12, 2007; (2007) dyl275v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Heeringa, D. A. M. van der Kuip, A. Hofman, J. A. Kors, F. J. A. van Rooij, G. Y. H. Lip, and J. C. M. Witteman Subclinical Atherosclerosis and Risk of Atrial Fibrillation: The Rotterdam Study Arch Intern Med, February 26, 2007; 167(4): 382 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J G Williams, S E Roberts, M F Ali, W Y Cheung, D R Cohen, G Demery, A Edwards, M Greer, M D Hellier, H A Hutchings, et al. Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence Gut, February 1, 2007; 56(suppl_1): 1 - 113. [Full Text] [PDF]
|
|
|
|
|
|
G. J. Kelloff, S. M. Lippman, A. J. Dannenberg, C. C. Sigman, H. L. Pearce, B. J. Reid, E. Szabo, V. C. Jordan, M. R. Spitz, G. B. Mills, et al. Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward Clin. Cancer Res., June 15, 2006; 12(12): 3661 - 3697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Kamangar, G. M. Dores, and W. F. Anderson Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World J. Clin. Oncol., May 10, 2006; 24(14): 2137 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hsu, Y.-C. Shen, C.-C. Cheng, R.-L. Hong, C.-J. Chang, and A.-L. Cheng Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in taiwan: implication from age-period-cohort analysis. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 856 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Li, X. Zhang, G. Huang, X. Miao, L. Guo, D. Lin, and S.-H. Lu Identification of a novel polymorphism Arg290Gln of esophageal cancer related gene 1 (ECRG1) and its related risk to esophageal squamous cell carcinoma Carcinogenesis, April 1, 2006; 27(4): 798 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Mayne, H. A. Risch, R. Dubrow, W.-H. Chow, M. D. Gammon, T. L. Vaughan, L. Borchardt, J. B. Schoenberg, J. L. Stanford, A. B. West, et al. Carbonated Soft Drink Consumption and Risk of Esophageal Adenocarcinoma J Natl Cancer Inst, January 4, 2006; 98(1): 72 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Steyn, K. Sliwa, S. Hawken, P. Commerford, C. Onen, A. Damasceno, S. Ounpuu, S. Yusuf, and for the INTERHEART Investigators in Africa Risk Factors Associated With Myocardial Infarction in Africa: The INTERHEART Africa Study Circulation, December 6, 2005; 112(23): 3554 - 3561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hong, X. Miao, X. Zhang, F. Ding, A. Luo, Y. Guo, W. Tan, Z. Liu, and D. Lin The Role of P53 and MDM2 Polymorphisms in the Risk of Esophageal Squamous Cell Carcinoma Cancer Res., October 15, 2005; 65(20): 9582 - 9587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ilson Just When You Thought the Fluorouracil Debate Was Over: S-1 and Gastric Cancer J. Clin. Oncol., October 1, 2005; 23(28): 6826 - 6828. [Full Text] [PDF]
|
|
|
|
|
|
M. Nouraie, P. Pietinen, F. Kamangar, S. M. Dawsey, C. C. Abnet, D. Albanes, J. Virtamo, and P. R. Taylor Fruits, Vegetables, and Antioxidants and Risk of Gastric Cancer among Male Smokers Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2087 - 2092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Tan, X. Miao, L. Wang, C. Yu, P. Xiong, G. Liang, T. Sun, Y. Zhou, X. Zhang, H. Li, et al. Significant increase in risk of gastroesophageal cancer is associated with interaction between promoter polymorphisms in thymidylate synthase and serum folate status Carcinogenesis, August 1, 2005; 26(8): 1430 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Ajani Carcinoma of the Esophagus: Is Biology Screaming in My Deaf Ears? J. Clin. Oncol., July 1, 2005; 23(19): 4256 - 4258. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kawatu and N. LeLeiko Birth Weight, Gastroesophageal Reflux, and Adult Onset Esophageal Adenocarcinoma: A Relationship? AAP Grand Rounds, June 1, 2005; 13(6): 69 - 70. [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. POLEDNAK RECENT TRENDS IN INCIDENCE RATES FOR SELECTED ALCOHOL-RELATED CANCERS IN THE UNITED STATES Alcohol Alcohol., May 1, 2005; 40(3): 234 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Savage, C. C. Abnet, S. D. Mark, Y.-L. Qiao, Z.-W. Dong, S. M. Dawsey, P. R. Taylor, and S. J. Chanock Variants of the IL8 and IL8RB Genes and Risk for Gastric Cardia Adenocarcinoma and Esophageal Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2251 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sun, X. Miao, X. Zhang, W. Tan, P. Xiong, and D. Lin Polymorphisms of Death Pathway Genes FAS and FASL in Esophageal Squamous-Cell Carcinoma J Natl Cancer Inst, July 7, 2004; 96(13): 1030 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Hao, H. Wang, K. Zhou, Y. Li, X. Chen, G. Zhou, Y. Zhu, X. Miao, W. Tan, Q. Wei, et al. Identification of Genetic Variants in Base Excision Repair Pathway and Their Associations with Risk of Esophageal Squamous Cell Carcinoma Cancer Res., June 15, 2004; 64(12): 4378 - 4384. [Abstract] [Full Text] [PDF]
|
|